Published within
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Favorable legislation and recent commercial successes have stimulated growing interest in the discovery of novel orphan drugs. However, there are many strategic considerations that are peculiar to the R&D process for diseases of low prevalence.
Published By Datamonitor
|
31 Aug 2012 |
$3800
|
Report
|
Qualitative and quantitative assessment of how biomarkers can change the diagnostic and commercial landscape in Alzheimer’s disease. The analysis provides an outline of the opportunities for drug and diagnostics companies in the Alzheimer’s market.
Published By Datamonitor
|
02 Dec 2011 |
$3800
|
Report
|
This report provides an analysis of strategies and trends employed by companies operating in the in vitro diagnostics (IVDs) market in order to drive revenue growth.
Published By Datamonitor
|
17 Jul 2012 |
$3800
|
Report
|
Image-guided and robot-assisted surgeries are rapidly developing surgical specialties, where ongoing technical innovations are improving healthcare efficiency as well as patient outcomes and experiences.
Published By Datamonitor
|
03 Dec 2012 |
$3800
|
Report
|
Innovations in anterior segment ophthalmic devices will grow the market for presbyopia treatments and improve visual outcomes. They will also provide earlier diagnoses of dry eye and offer benefits in refractive and cataract surgery.
Published By Datamonitor
|
18 Oct 2012 |
$3800
|
Report
|
Diversification is one strategy Big Pharma is using to contend with the oncoming patent cliff, however, Datamonitor has analyzed ten sectors within healthcare and concluded that remaining pharma-focused will lead to maximum revenue growth.
Published By Datamonitor
|
12 Nov 2009 |
$7600
|
Report
|
Micro and nanotechnologies are set to transform point-of-care diagnostics. Miniaturization of testing methods, advances in lab-on-a-chip microfluidic methodologies, improvements in detection technologies and novel biosensors are leading the way.
Published By Datamonitor
|
17 Oct 2012 |
$3800
|
Report
|
An overview of merger and acquisition (M&A) trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q1 2007 to Q1 2010, with discussion of the drivers of recent deals and analysis of key M&As in individual countries.
Published By Datamonitor
|
19 Aug 2010 |
$7600
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.